ArticleMedical devices (Auckland, N.Z.)2018

In vitro study of RRS® Silisorg CE Class III medical device composed of silanol: effect on human skin fibroblasts and its clinical use.

Pierre-Antoine Deglesne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.